Rapalink-1
Rapalink-1 is a drug which acts as an inhibitor of the enzyme mechanistic target of rapamycin (mTOR).
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Rapalink-1 is a drug which acts as an inhibitor of the enzyme mechanistic target of rapamycin (mTOR). It is a dimeric molecule consisting of rapamycin joined to a desalkyl derivative of sapanisertib by a linker group.
Since both of these products inhibit mTOR but through action at distinct binding sites on the mTOR complex, it exhibits a dual mTOR inhibitory activity and has been suggested for applications as an anti-aging drug or for treatment of some forms of cancer. Rapalink-1 is synthesized using click chemistry, specifically through a copper-catalyzed azide-alkyne cycloaddition to join rapamycin and sapanisertib, an mTOR active-site inhibitor via a polyethylene glycol linker.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1368825354 under CC BY-SA 4.0; modifications have been made.